Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sommermeyer

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Leukemia|February 17, 2017
Fully human CD19-specific chimeric antigen receptors for T-cell therapyD Sommermeyer, T Hill, S M Shamah, et al.
Leukemia|September 16, 2015
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivoD Sommermeyer, M Hudecek, P L Kosasih, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Leukemia|February 17, 2017
Fully human CD19-specific chimeric antigen receptors for T-cell therapyD Sommermeyer, T Hill, S M Shamah, et al.
Leukemia|September 16, 2015
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivoD Sommermeyer, M Hudecek, P L Kosasih, et al.
Pageof 1